The Peculiar Implications of Immune-mediated Optic Neuritis at Disease Presentation in Brazil. Study of 271 Patients.

- 307021
Happy Poster
Favorite this paper
How to cite this paper?
Abstract

Introduction – Immune-mediated optic neuritis (IMON) is an initial symptom in various demyelinating diseases of the CNS (DDCNS). These conditions  exihibit different epidemiological and clinical features in Brazil compared to other Western countries. Understanding the characteristics and frequencies of these underlying conditions in Brazil is crucial for designing public health strategies aimed at early intervention and prevention of more severe outcomes. Objective – To describe the characteristics and frequencies of IMON as the presenting symptom of DDCNS. Methods – We retrospectively selected a cohort of patients with IMON at onset of a DDCNS. IMON-related to multiple sclerosis (MSRON) comprised single isolated optic neuritis (SION), and ON in multiple sclerosis (MSON). Non-related to MS-ON  comprised recurring isolated ON (RION), chronic reccurring inflammatory optic neuropathy (CRION), myelin oligodendrocytic glycoprotein-associated ON (MOGAD-ON), neuromyelitis optica ON (NMOSD-ON), ON in association with systemic autoimmune diseases (SAD-ON); parainfectious ON (PION); and vaccine-related ON (VON). Severity of ON was measured by Kurtzke’s Visual Function System Scores (KVFSS). Results – Analysis of 271 IMON patients revealed a mean age of 31.3 ±13 years; with 214 (79%) women. Non-Caucasians comprised 52%, and 13.3% had an associated autoimmune disease. Isolated ON occurred in 70.8%, and bilateral simultaneous ON in 32.5%. The median KVFSS was 2 (range 1-5). MSRON was identified in 101 (37.3%) patients, AQP4-seropositive NMOSD-ON in 36 (13.3%), RION in 26 (9.6%), MOGAD-ON in 14 (5.2%), CRION 2 (0.7%), 7 (2.6%) in ADEM-ON; PION in 7 (2.6%), PV-ON in 14 (5.2%), and SAD in 7  (2.6%) patients. The etiology remained undetermined in 20 (7.4%) patients. Conclusions – Compared to data from other Western populations, in Brazil IMON is more prevalent in non-Caucasians and NMOSD-ON, less so in MS and MOGAD, and is associated with more severe outcomes. These findings underscore the need for tailored healthcare policy in the country.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 CIEM MS Research Center, Federal University of Minas Gerais Medical School, Belo Horizonte, MG, Brazil.
Track
  • 6. NMO, ADEM and CIS
Keywords
Immune-mediated optic neuritis
demyelinating diseases
presenting symptom
multiple sclerosis
healthcare policy